The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
Open accessAbstract
(R)-Roscovitine, a pharmacological inhibitor of kinases, is currently in phase II clinical trial as a drug candidate for the treatment of cancers, Cushing's disease and rheumatoid arthritis. We here review the data that support the investigation of (R)-roscovitine as a potential therapeutic agent for the treatment of cystic fibrosis (CF). (R)-Roscovitine displays four independent properties that may favorably combine against CF: (1) it partially protects F508del-CFTR from proteolytic degradation and favors its trafficking to the plasma membrane; (2) by increasing membrane targeting of the TRPC6 ion channel, it rescues acidification in phagolysosomes of CF alveolar macrophages (which show abnormally high pH) and consequently restores their bactericidal activity; (3) its effects on neutrophils (induction of apoptosis), eosinophils (inhibition of degranulation/induction of apoptosis) and lymphocytes (modification of the Th17/Treg balance in favor of the differentiation of anti-inflammatory lymphocytes and reduced production of various interleukins, notably IL-17A) contribute to the resolution of inflammation and restoration of innate immunity, and (4) roscovitine displays analgesic properties in animal pain models. The fact that (R)-roscovitine has undergone extensive preclinical safety/pharmacology studies, and phase I and II clinical trials in cancer patients, encourages its repurposing as a CF drug candidate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–272 of 272
Lung inflammation in cystic fibrosis: Pathogenesis and novel therapies
Dhooghe, B., Noël, S., Huaux, F., & Leal, T. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.12.020 · Cited by 56
Does NETosis Contribute to the Bacterial Pathoadaptation in Cystic Fibrosis?
Rahman, S., & Gadjeva, M. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00378 · Cited by 56
The CDK inhibitor, R‐roscovitine, promotes eosinophil apoptosis by down‐regulation of Mcl‐1
Duffin, R., Leitch, A. E., Sheldrake, T. A., Hallett, J. M., Meyer, C., Fox, S., Alessandri, A. L., Martin, M. C., Brady, H. J. M., Teixeira, M. M., et al. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.017 · Cited by 55
Self-citationSHEA, T. B., Zheng, Y., Ortiz, D., & Pant, H. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20099 · Cited by 55
Aldoss, I. T., Tashi, T., & Ganti, A. K. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903418445 · Cited by 55
The Microbiome and Emerging Pathogens in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis
Green, H. J., & Jones, A. M. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1546752 · Cited by 53
NETs and CF Lung Disease: Current Status and Future Prospects
Gray, R. D., McCullagh, B. N., & McCray, P. B. (2015) · Antibiotics · doi:10.3390/antibiotics4010062 · Cited by 52
Self-citationPhysiological Functions and Regulation of TRPC Channels
Ong, H. L., de Souza, L. B., Cheng, K. T., & Ambudkar, I. S. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-05161-1_12 · Cited by 52
Current concepts of immune dysregulation in cystic fibrosis
Rieber, N. P., Hector, A., Carevic, M., & Hartl, D. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.01.017 · Cited by 51
Zoja, C., Casiraghi, F., Conti, S., Corna, D., Rottoli, D., Cavinato, R. A., Remuzzi, G., & Benigni, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22593 · Cited by 51
Du, J., Wei, N., Guan, T., Xu, H., An, J., Pritchard, K. A., & Shi, Y. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00138.2009 · Cited by 49
Pharmacokinetic model of R-roscovitine and its metabolite in healthy male subjects
de la Motte, S., & Gianella-Borradori, A. (2004) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42232 · Cited by 49
Intrinsic predisposition of naïve cystic fibrosis T cells to differentiate towards a Th17 phenotype
Kushwah, R., Gagnon, S., & Sweezey, N. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-138 · Cited by 48
E-selectin permits communication between PAF receptors and TRPC channels in human neutrophils
McMeekin, S. R., Dransfield, I., Rossi, A. G., Haslett, C., & Walker, T. R. (2006) · Blood · doi:10.1182/blood-2005-09-3803 · Cited by 46
Self-citationLiu, J., Du, J., Yang, Y., & Wang, Y. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.09.005 · Cited by 46
Peng, H., Chen, G., Tung, K., Lai, C., Hsien, M.-C., Chiu, C.-H., Lu, H.-T., Liao, J.-M., Lee, S., & Lin, T.-B. (2009) · Pain · doi:10.1016/j.pain.2008.11.017 · Cited by 46
Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects
Hirasawa, M., Ohshima, T., Takahashi, S., Longenecker, G., Honjo, Y., Veeranna, Pant, H. C., Mikoshiba, K., Brady, R. O., & Kulkarni, A. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307322101 · Cited by 46
Self-citationMoskowitz, S. M., Gibson, R. L., & Effmann, E. L. (2005) · Pediatric Radiology · doi:10.1007/s00247-005-1445-3 · Cited by 45
R-roscovitine Reduces Lung Inflammation Induced by Lipoteichoic Acid and Streptococcus pneumoniae
Hoogendijk, A. J., Roelofs, J. J. T. H., Duitman, J., van Lieshout, M. H. P., Blok, D. C., van der Poll, T., & Wieland, C. W. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00033 · Cited by 44
High Peripheral Blood Th17 Percent Associated with Poor Lung Function in Cystic Fibrosis
Mulcahy, E. M., Hudson, J. B., Beggs, S. A., Reid, D. W., Roddam, L. F., & Cooley, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120912 · Cited by 44
Zhang, X., Zhang, H., Shao, H., Xue, Q., & Yu, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087788 · Cited by 44
Raynaud, F. I., Fischer, P. M., Nutley, B. P., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.353.3.3 · Cited by 44
Discovery of novel inhibitors for the treatment of glaucoma
Cholkar, K., Trinh, H. M., Pal, D., & Mitra, A. K. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1000857 · Cited by 43
Wen, H., Linhoff, M. W., Hubbard, J. M., Nelson, N. R., Stensland, D., Dallman, J. E., Mandel, G., & Brehm, P. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5839-12.2013 · Cited by 42
Kukavica‐Ibrulj, I., Facchini, M., Cigana, C., Lévesque, R. C., & Bragonzi, A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0473-0_58 · Cited by 42
Jhou, R., Sun, K., SUN, G.-H., Wang, H., Chang, C., Huang, H., Lu, S., & Tang, S. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00584.x · Cited by 40
Inflammation and CFTR: Might Neutrophils be the Key in Cystic Fibrosis?
Witko‐Sarsat, V., Sermet‐Gaudelus, I., Lenoir, G., & Descamps‐Latscha, B. (1999) · Mediators of Inflammation · doi:10.1080/09629359990658 · Cited by 40
Self-citationNorez, C., Vandebrouck, C., Bertrand, J., Noël, S., Durieu, É., Oumata, N., Galons, H., Antigny, F., Chatelier, A., Bois, P., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12859 · Cited by 39
Self-citationPutative therapeutic agents for the learning and memory deficits of people with Down syndrome
Kim, N. D., Yoon, J.-H., Kim, J. H., Lee, J. T., Chon, Y. S., Hwang, M.-K., Ha, I., & Song, W. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.04.042 · Cited by 39
Use of Kinase Inhibitors to Correct ΔF508-CFTR Function
Trzcińska-Daneluti, A. M., Nguyen, L., Jiang, C., Fladd, C., Uehling, D., Prakesch, M. A., Al‐awar, R., & Rotin, D. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016626 · Cited by 39
Roscovitine blocks leukocyte extravasation by inhibition of cyclin‐dependent kinases 5 and 9
Berberich, N., Uhl, B., Joore, J., Schmerwitz, U. K., Mayer, B. A., Reichel, C. A., Krombach, F., Zahler, S., Vollmar, A. M., & Fürst, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01309.x · Cited by 38
Radioimmunoassay for leukotriene B 4
Lewis, R. A., Mencia‐Huerta, J., Soberman, R. J., et al. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7904 · Cited by 38
Alessandri, A. L., Duffin, R., Leitch, A. E., Lucas, C. D., Sheldrake, T. A., Dorward, D. A., Hirani, N., Pinho, V., Sousa, L. P., Teixeira, M. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025683 · Cited by 37
Self-citationPain in CF: Review of the literature
Havermans, T., Colpaert, K., Boeck, K. D., Dupont, L., & Abbott, J. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.04.001 · Cited by 36
Zhang, H., Zhang, X., Wang, W., Xue, Q., Han, L., Huang, J., Gui, T., & Yu, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046666 · Cited by 35
Cosimo, E., McCaig, A. M., Carter-Brzezinski, L. J. M., Wheadon, H., Leach, M. T., Ster, K. L., Berthou, C., Durieu, É., Oumata, N., Galons, H., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2170 · Cited by 35
Self-citationHuman eosinophils are more toxic than neutrophils in antibody-independent killing
Roberts, R. L., Ank, B. J., & Stiehm, E. R. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)92156-u · Cited by 33
New Perspectives in the Management of Pseudomonas Aeruginosa Infections
Savoia, D. (2014) · Future Microbiology · doi:10.2217/fmb.14.42 · Cited by 33
Emerging drugs for cystic fibrosis
Amin, R., & Ratjen, F. A. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.882316 · Cited by 32
Koller, D. Y., Nilsson, M., Enander, I., et al. (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00216.x · Cited by 32
Practical Synthesis of Roscovitine and CR8
Oumata, N., Ferandin, Y., Meijer, L., & Galons, H. (2009) · Organic Process Research & Development · doi:10.1021/op800284k · Cited by 31
Self-citationMilovanceva-Popovska, M., Kunter, U., Ostendorf, T., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00213.x · Cited by 30
Effects of the cyclin‐dependent kinase inhibitor R‐roscovitine on eosinophil survival and clearance
Farahi, N., Uller, L., Juss, J. K., Langton, A. J., Cowburn, A. S., Gibson, A., Foster, M. R., Farrow, S. N., Marco‐Casanova, P., Sobolewski, A., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03680.x · Cited by 29
The BDNF/TrkB Signaling Pathway Is Involved in Heat Hyperalgesia Mediated by Cdk5 in Rats
Zhang, H., Zhang, X., Xue, Q., YanLuo, Huang, J., Zhang, S., Shao, H., Han, L., Wang, W., & Yu, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085536 · Cited by 29
Molecular roles of Cdk5 in pain signaling
Utreras, E., Futatsugi, A., Pareek, T. K., & Kulkarni, A. B. (2009) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2009.04.004 · Cited by 29
Self-citationZhang, R., Liu, Y., Zhang, J., Zheng, Y., Gu, X., & Ma, Z. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.025 · Cited by 29
Li, L., Wang, H., Kim, J. S., Pihan, G. A., & Boussiotis, V. A. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8738 · Cited by 29
Fang-Hu, Zhang, H.-H., Yang, B., Huang, J.-L., Shun, J., Kong, F., Peng-Xu, Chen, Z.-G., & Lu, J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.056 · Cited by 28
Synthesis and Biological Evaluation of a Selective N- and P/Q-Type Calcium Channel Agonist
Liang, M., Tarr, T. B., Bravo‐Altamirano, K., Valdomir, G., Rensch, G., Swanson, L., DeStefino, N. R., Mazzarisi, C. M., Olszewski, R. A., Wilson, G. M., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3002083 · Cited by 27
Halmerbauer, G., Arri, S., Schierl, M., Strauch, E., & Koller, D. Y. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00988.x · Cited by 26
A Cdk5 Inhibitor Enhances the Induction of Insulin Secretion by Exendin-4 Both in Vitro and in Vivo
Kitani, K., Oguma, S., Nishiki, T., Ohmori, I., Galons, H., Matsui, H., Meijer, L., & Tomizawa, K. (2007) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rp006607 · Cited by 25
Self-citationNon-tuberculous mycobacteria in cystic fibrosis
Hill, U. G., Floto, R. A., & HAWORTH, C. S. (2012) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2012.12s003 · Cited by 25
The Development of Lung Disease in Cystic Fibrosis Pigs
Wine, J. J. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001130 · Cited by 24
Yoshida, H., Kotani, H., Kondo, T., Tani, I., Wei, X., Tsuruta, S., Kimura, A., Asakawa, M., Ito, M., Nagai, S., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.096 · Cited by 24
Activation of Cyclin-Dependent Kinase 5 Mediates Orofacial Mechanical Hyperalgesia
Prochazkova, M., Terse, A., Amin, N. D., Hall, B., Utreras, E., Pant, H. C., & Kulkami, A. B. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-66 · Cited by 24
Self-citationEpigenetic modulation of Cdk5 contributes to memory deficiency induced by amyloid fibrils
Li, L., Zhang, C., Zi, X., Tu, Q., & Guo, K. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-4100-0 · Cited by 21
Gautam, S., Kirschnek, S., Wiesmeier, M., Vier, J., & Häcker, G. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079352 · Cited by 21
Could T cells be involved in lung deterioration and hyperglycemia in cystic fibrosis?
Ziai, S., Coriati, A., Gauthier, M., RABASA-LHORET, R. P. R., & Richter, M. V. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.002 · Cited by 21
Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
Steinman, R. A., Robinson, A. R., & Feghali‐Bostwick, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048560 · Cited by 20
Highlights of a workshop to discuss targeting inflammation in cystic fibrosis
Banner, K. H., de Jonge, H. R., Elborn, J. S., Growcott, E. J., Gulbins, E., Konstan, M., Moss, R., Poll, C. T., Randell, S. H., Rossi, A. G., et al. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.10.002 · Cited by 20
Self-citationChagniel, L., Robitaille, C., Lebel, M., & Cyr, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.011 · Cited by 20
Intrathecal cdk5 inhibitor, roscovitine, attenuates morphine antinociceptive tolerance in rats.
Wang, C. H., Lee, T.-H., Tsai, Y. J., Liu, J. K., Chen, Y. J., Yang, L. C., & Lu, C. Y. (2004) · PubMed · Cited by 19
Yang, H. Y., & Ma, T. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1045878 · Cited by 16
Gu, H., Ding, L., Xiong, S., Gao, X., & Zheng, B. Q. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.05.004 · Cited by 14
Hoogendijk, A. J., Kuipers, M. T., van der Poll, T., Schultz, M. J., & Wieland, C. W. (2012) · Shock · doi:10.1097/shk.0b013e3182656e7b · Cited by 14
Jovic, S., Shikhagaie, M., Mörgelin, M., Kjellström, S., Erjefalt, J. S., Olin, A. I., Frick, I.-M., & Egesten, A. (2014) · Journal of Innate Immunity · doi:10.1159/000365399 · Cited by 13
Das, R. R., Kabra, S. K., & Singh, M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/645653 · Cited by 10
Goralski, J. L., & Davis, S. D. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23253 · Cited by 9
T-Cell Immunotherapy in Cystic Fibrosis
Robinson, K. M., & Alcorn, J. F. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2201ed · Cited by 9
Editorial: Maintaining the balance—fishing for drugs to treat persistent neutrophilic inflammation
Hall, C. J., & Crosier, P. S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909647 · Cited by 4
Progress Towards Next-Generation Therapeutics for Cystic Fibrosis
O′Neil, D. A., & Fraser-Pitt, D. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.67 · Cited by 2
Targeting the Root Cause of Cystic Fibrosis
Trescott, L., Holcomb, J., Spellmon, N., McLeod, C. M., Aljehane, L., Sun, F., Li, C., & Yang, Z. (2015) · Current Drug Targets · doi:10.2174/1389450115999141030144247 · Cited by 2
Research works printed but not linked: 27
- 10.1159/000350215 · doi:10.1159/000350215
- 10.1021/ar0201198 · doi:10.1021/ar0201198
- 10.1097/01.ASN.0000124672.41036.F4 · doi:10.1097/01.asn.0000124672.41036.f4
- 10.1111/nyas.12001 · doi:10.1111/nyas.12001
- 10.1096/fj.03-0035fje · doi:10.1096/fj.03-0035fje
- 10.1158/1078-0432.CCR-08-1748 · doi:10.1158/1078-0432.ccr-08-1748
- 10.1530/REP-07-0069 · doi:10.1530/rep-07-0069
- 10.4161/cbt.4.1.1462 · doi:10.4161/cbt.4.1.1462
- 10.2174/156802611795589601 · doi:10.2174/156802611795589601
- 10.2174/1568026611313030008 · doi:10.2174/1568026611313030008
- 10.1111/bph.12723 · doi:10.1111/bph.12723
- 10.1042/BJ20021975 · doi:10.1042/bj20021975
- 10.2174/138920111793937943 · doi:10.2174/138920111793937943
- 10.1177/1947601910369817 · DOI
- 10.1016/j.jcf.2012.07.003 · DOI · Paper page
- 10.1159/000350215 · doi:10.1159/000350215
- 10.1136/thx.2008.096834 · doi:10.1136/thx.2008.096834
- 10.1159/000295791 · doi:10.1159/000295791
- 10.1136/thx.49.5.496 · doi:10.1136/thx.49.5.496
- 10.1111/imm.12416 · DOI
- 10.3109/08820139.2014.888447 · doi:10.3109/08820139.2014.888447
- 10.1371/journal.pone.0081154 · DOI
- 10.1097/MEG.0000000000000011 · doi:10.1097/meg.0000000000000011
- 10.1007/s10072-014-1713-9 · doi:10.1007/s10072-014-1713-9
- 10.1016/j.brainresbull.2014.04.008 · doi:10.1016/j.brainresbull.2014.04.008
- 10.1111/j.1745-7254.2005.00007.x · doi:10.1111/j.1745-7254.2005.00007.x
- 10.2174/1574892810666150617112230 · doi:10.2174/1574892810666150617112230
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Neutrophil extracellular traps in immunity and disease
Papayannopoulos, V. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.105 · Cited by 3,397
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citation
Metadata
- Authors
- Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., Gueganton, L., Dorothée, G., Prochazkova, M., Hall, B., Kulkarni, A. B., Gray, R. D., Rossi, A. G., Witko-Sarsat, V., Norez, C., Becq, F., Ravel, D., Mottier, D., & Rault, G.
- Venue
- Journal of Innate Immunity
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 8
- Issue
- 4
- Pages
- 330-349
- ISSN
- 1662-811X (ISSN-L)
- 1662-8128
- OpenAlex
- W2301131921
- Cited by
- 4,992
- References
- 272
- FWCI
- 438.81
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.